BACKGROUND: Untreated latent TB infection (LTBI) is a significant risk factor for active pulmonary tuberculosis, hence predisposing to adverse pregnancy outcomes and mother to child transmission. The prevalence of latent tuberculosis in pregnancy and its association, if any, with various socio-demographic, obstetric and clinical characteristics was evaluated. METHODS: Northern Tanzania was chosen as the study site. In a cross-sectional study, a total of 286 pregnant women from 12 weeks gestational age to term were assessed. Screening was undertaken using an algorithm involving tuberculin skin testing, symptom screening in the form of a questionnaire, sputum testing for acid fast bacilli followed by shielded chest X-rays if indicated. HIV serology was also performed on consenting participants. RESULTS: Prevalence of latent infection ranged between 26.2% and 37.4% while HIV sero prevalence was 4.5%. After multivariate logistic analysis it was found that age, parity, body mass index, gestational age, and HIV sero status did not have any significant association with tuberculin skin test results. However certain ethnic groups were found to be less vulnerable to LTBI as compared to others (Chi square = 10.55, p = 0.03). All sputum smears for acid fast bacilli were negative. CONCLUSION: The prevalence of latent tuberculosis in pregnant women was found to be relatively high compared to that of the general population. In endemic areas, socio-demographic parameters alone are rarely adequate in identifying women susceptible to TB infection; therefore targeted screening should be conducted for all pregnant women at high risk for activation (especially HIV positive women). As opposed to the current policy of passive case detection, there appears to be an imminent need to move towards active screening. Ethnicity may provide important clues into genetic and cultural differences which predispose to latent tuberculosis, and is worth exploring further.
BACKGROUND: Untreated latent TB infection (LTBI) is a significant risk factor for active pulmonary tuberculosis, hence predisposing to adverse pregnancy outcomes and mother to child transmission. The prevalence of latent tuberculosis in pregnancy and its association, if any, with various socio-demographic, obstetric and clinical characteristics was evaluated. METHODS: Northern Tanzania was chosen as the study site. In a cross-sectional study, a total of 286 pregnant women from 12 weeks gestational age to term were assessed. Screening was undertaken using an algorithm involving tuberculin skin testing, symptom screening in the form of a questionnaire, sputum testing for acid fast bacilli followed by shielded chest X-rays if indicated. HIV serology was also performed on consenting participants. RESULTS: Prevalence of latent infection ranged between 26.2% and 37.4% while HIV sero prevalence was 4.5%. After multivariate logistic analysis it was found that age, parity, body mass index, gestational age, and HIV sero status did not have any significant association with tuberculin skin test results. However certain ethnic groups were found to be less vulnerable to LTBI as compared to others (Chi square = 10.55, p = 0.03). All sputum smears for acid fast bacilli were negative. CONCLUSION: The prevalence of latent tuberculosis in pregnant women was found to be relatively high compared to that of the general population. In endemic areas, socio-demographic parameters alone are rarely adequate in identifying women susceptible to TB infection; therefore targeted screening should be conducted for all pregnant women at high risk for activation (especially HIV positive women). As opposed to the current policy of passive case detection, there appears to be an imminent need to move towards active screening. Ethnicity may provide important clues into genetic and cultural differences which predispose to latent tuberculosis, and is worth exploring further.
Authors: T Pillay; A W Sturm; M Khan; M Adhikari; J Moodley; C Connolly; D Moodley; N Padayatchi; A Ramjee; H M Coovadia; J L Sullivan Journal: Int J Tuberc Lung Dis Date: 2004-01 Impact factor: 2.373
Authors: S den Boon; S W P van Lill; M W Borgdorff; S Verver; E D Bateman; C J Lombard; D A Enarson; N Beyers Journal: Thorax Date: 2005-07 Impact factor: 9.139
Authors: Frank G Cobelens; Saidi M Egwaga; Tessa van Ginkel; Hemed Muwinge; Mecky I Matee; Martien W Borgdorff Journal: Clin Infect Dis Date: 2006-07-12 Impact factor: 9.079
Authors: Collins K Boahen; Godfrey S Temba; Vesla I Kullaya; Vasiliki Matzaraki; Leo A B Joosten; Gibson Kibiki; Blandina T Mmbaga; Andre van der Ven; Quirijn de Mast; Mihai G Netea; Vinod Kumar Journal: Am J Hum Genet Date: 2022-02-14 Impact factor: 11.043
Authors: Felix Bongomin; Phillip Ssekamatte; Gloria Nattabi; Ronald Olum; Sandra Ninsiima; Andrew Peter Kyazze; Winnie Nabakka; Rebecca Kukunda; Stephen Cose; Davis Kibirige; Charles Batte; Mark Kaddumukasa; Bruce J Kirenga; Annettee Nakimuli; Joseph Baruch Baluku; Irene Andia-Biraro Journal: Open Forum Infect Dis Date: 2021-05-11 Impact factor: 3.835
Authors: Andreas V Jensen; Lotte Jensen; Daniel Faurholt-Jepsen; Martine G Aabye; George Praygod; Jeremiah Kidola; Maria Faurholt-Jepsen; John Changalucha; Nyagosya Range; Henrik Krarup; Henrik Friis; Aase B Andersen Journal: PLoS One Date: 2013-05-21 Impact factor: 3.240